miR-3148-overexpressing HCT116 cells exhibited enhanced tumor formation in vivo, were resistant to hypoxic conditions and exhibited higher sensitivity to MAPKK and ERK inhibitors39. The gene discussed is MAPK1; the disease is neoplasm.